Position
Chief Legal Officer
Company
ARS Pharmaceuticals, Inc.
SeattleInformation TechnologyBiotechnologyDescription
John Slebir became Chief Legal Officer of ARS Pharmaceuticals, Inc. on October 26, 2026, per the SEC Form 3 filed November 4, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
Who to call at ARS Pharmaceuticals, Inc., and when
A new leader at ARS Pharmaceuticals, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ARS Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARS Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARS Pharmaceuticals, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARS Pharmaceuticals, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ARS Pharmaceuticals, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.